Mir526b and Mir655 Promote Tumour Associated Angiogenesis and Lymphangiogenesis in Breast Cancer

  title={Mir526b and Mir655 Promote Tumour Associated Angiogenesis and Lymphangiogenesis in Breast Cancer},
  author={Stephanie Hunter and Braydon Nault and Kingsley Chukwunonso Ugwuagbo and Sujit Maiti and Mousumi Majumder},
MicroRNAs (miRNAs) are small endogenously produced RNAs, which regulate growth and development, and oncogenic miRNA regulate tumor growth and metastasis. Tumour-associated angiogenesis and lymphangiogenesis are processes involving the release of growth factors from tumour cells into the microenvioronemnt to communicate with endothelial cells to induce vascular propagation. Here, we examined the roles of cyclo-oxygenase (COX)-2 induced miR526b and miR655 in tumour-associated angiogenesis and… 

Figures and Tables from this paper

ZKSCAN5 Activates VEGFC Expression by Recruiting SETD7 to Promote the Lymphangiogenesis, Tumour Growth, and Metastasis of Breast Cancer

The role of the transcription factor zinc finger with KRAB and SCAN domains 5 (ZKSCAN5) in interacting with histone methyltransferase SETD7 and mediating VEGFC transcription and tumour lymphangiogenesis is identified and predicted as a breast cancer therapeutic target.

Chemically Induced Hypoxia Enhances miRNA Functions in Breast Cancer

Hypoxia enhances miRNA functions following the COX-2/EP4/PI3K/Akt pathways and this pathway can serve as a therapeutic target to abrogate hypoxia and miRNA induced functions in breast cancer.

miR-503-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-A

Downregulation of miR-503-5p at least partially contributes to the tumorigenesis of colon cancer through modulating the angiogenesis and lymphangiogenesis by targeting VEGF-A while stimulating AKT signaling pathways.

EP4 as a Therapeutic Target to Impede Breast Cancer-associated Angiogenesis and Lymphangiogenesis

It is shown that COX-2 is a major promoter of both events, primarily resulting from the activation of Prostaglandin E receptor EP4 on tumor cells, tumor-infiltrating immune cells, and endothelial cells; and induction of oncogenic microRNAs.

Mir-455-3p Inhibits Hepatocellular Carcinoma Tumorigenesis, Lymphangiogenesis and Angiogenesis via Regulating Vascular Endothelial Growth Factor C as well as Vascular Endothelial Growth Factor Receptor-2

The findings suggest that miR-455-3p could play a role in HCC tumorigenesis at least in part by modulation of angiogenesis and lymphangiogenesis through targeting VEGFC, and could simultaneously block AKT signaling pathways.

MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets

The recent updates on miRNA signatures and their cellular targets in the development of breast tumor angiogenetic are summarized and the strategies associated with miRNA-based therapeutic targets as anti-angiogenic response are discussed.

miR526b and miR655 Induce Oxidative Stress in Breast Cancer

The dynamic functions of miR526b/miR655 in oxidative stress induction in breast cancer are established, and treatment with miRNA-conditioned media upregulates TXNRD1 in both MCF7 and HUVECs, indicating that oxidative stress also induces miRNA overexpression.

Angioregulatory microRNAs in Colorectal Cancer

The aim of this article is to review the current literature on angioregulatory miRNAs in CRC and to understand the interaction between these miRNA and their target mRNAs to unravel molecular mechanisms involved in CRC progression.



Tumor-derived microRNA-494 promotes angiogenesis in non-small cell lung cancer

Delivery of miR-494 into human vascular endothelial cells (ECs) enhanced the EC migration and promoted angiogenesis and tumor growth under hypoxic condition and demonstrated that miR -494 is a novel tumor-derived paracrine signal to promote angiogenic and tumor Growth under hypoxia.

Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer

The role of miR-155 in angiogenesis through targeting von Hippel-Lindau (VHL) tumour suppressor in breast cancer is demonstrated and it is indicated that mi R-155 has a pivotal role in tumour angiogenic by downregulation of VHL.

Downregulation of miR-126 induces angiogenesis and lymphangiogenesis by activation of VEGF-A in oral cancer

A significant association was found between miR-126 expression and tumour progression, nodal metastasis, vessel density, or poor prognosis in OSCC cases.

Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model

It is suggested that EP4 antagonists deserve clinical testing for chemo-intervention of lymphatic metastasis in human breast cancer.

COX-2 induces oncogenic micro RNA miR655 in human breast cancer

It is shown that Cyclooxygenase-2 over-expression induces an oncogenic microRNA miR655 in human breast cancer cells by activation of EP4 and this expression could serve as a prognostic breast cancer biomarker.

Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer

It is shown that cyclooxygenase (COX)-2 expression by breast cancer cells or tumor stroma leading to high PGE2 levels in the tumor milieu promotes lymphangiogenesis and lymphatic metastases, and a case is made for EP4 as a potential therapeutic target for breast cancer.

COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation

Novel findings are presented that miRNA 526b is a COX-2 upregulated, oncogenic miRNA promoting SLCs, the expression of which follows EP4 receptor-mediated signaling, and is a promising biomarker for monitoring and personalizing breast cancer therapy.

Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro

VEGF-A production by and VEGFR-2 activation on the surface of breast cancer cells indicates the presence of a distinct autocrine signalling loop that enables breast cancers cells to promote their own growth and survival by phosphorylation and activation of VEG FR-2.

MiR-182 promotes proliferation and invasion and elevates the HIF-1α-VEGF-A axis in breast cancer cells by targeting FBXW7.

This study showed that overexpression miR-182 regulated actin distribution and filopodia formation to increase invasiveness of breast cancer cells and identified the E3 ubiquitin-protein ligase FBXW7 as a target gene of mi R-182.